Diclofenac Sodium USP (Micronized) For Compounding (API)

Diclofenac Sodium USP (Micronized) for Compounding (API) is a pharmaceutical-grade active ingredient used for creating customized medications, often for compounding prescriptions in specialized pharmacy settings. It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class and is primarily used for its analgesic, anti-inflammatory, and antipyretic properties. This makes it effective in managing pain and inflammation associated with conditions such as arthritis, musculoskeletal injuries, and postoperative pain. The micronized form of diclofenac sodium is designed to enhance absorption and bioavailability, thus optimizing its therapeutic efficacy in compounded formulations.

Diclofenac Sodium USP (Micronized) is a type of drug that is used to relieve pain and inflammation in conditions such as arthritis. It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class and is often prescribed for conditions that involve joint pain, such as osteoarthritis and rheumatoid arthritis.

The "micronized" designation refers to the process of grinding the particles of the drug to a smaller size, which allows for better absorption and effectiveness. This type of diclofenac is commonly used for compounding, which is the process of preparing customized medications to meet individual patient needs. Compounding is often used to create alternate formulations or strengths of medications or to combine multiple active ingredients into one medication.
Diclofenac Sodium USP (Micronized) is used for compounding to provide customized pain relief for patients with specific needs or sensitivities that may not be met by commercially available medications. It should only be used under the direction and supervision of a trained healthcare professional.